18 November 2026
ADVERTISEMENT
ADVERTISEMENT

Pharma Marketing Rules: Supreme Court Asks Centre to Form Expert Committee

Can pharmaceutical companies offer freebies to doctors without stronger legal safeguards? The Supreme Court has asked the Centre to form a committee to recommend regulations on pharma marketing practices.
High Court Women Objectionable Remarks Review
Indian Masterminds Stories

New Delhi: The Supreme Court of India has directed the Central Government to form a committee to recommend stronger regulations against unethical pharmaceutical marketing practices, including the practice of offering freebies to doctors. 

The committee will examine whether existing rules are enough to prevent pharmaceutical companies from improperly influencing doctors’ prescribing decisions. 

The move aims to improve transparency, protect patients’ interests and strengthen accountability in the pharmaceutical industry. The Court has also asked the government to consider the committee’s recommendations and explain the action taken.

Details of Supreme Court Directives on Pharma Marketing Rules

On October 8, 2026, a bench of the Supreme Court comprising Justice Vikram Nath and Justice Sandeep Mehta directed the Union Government to establish a committee to examine unethical marketing practices by pharmaceutical companies.

Read also: Why The Supreme Court Has Ordered A Major Crackdown On Dowry Cases Across India

The committee will study the existing rules and recommend whether a stronger legal framework is needed to regulate the pharmaceutical industry.

The Court said that having rules on paper is not enough. These rules must also be properly implemented and enforced to protect public health. The government must consider the committee’s recommendations and take an appropriate decision. The case is scheduled for further hearing on January 29, 2027.

Why Are Pharmaceutical Companies Offering Freebies To Doctors Under Scrutiny

Pharmaceutical companies promote their medicines to doctors to encourage their use and prescriptions. However, problems can arise when companies offer personal benefits to influence doctors’ decisions.

These benefits may include gifts, travel facilities, hospitality, monetary benefits or sponsorship for medical events. Such practices can create a conflict of interest. A doctor should recommend a medicine because it is suitable for the patient’s medical needs, not because a company has offered personal benefits.

The main concern is that patients could receive expensive medicines when more affordable and equally suitable alternatives are available.

The Supreme Court has previously highlighted these concerns in Apex Laboratories Pvt. Ltd. v. Deputy Commissioner of Income Tax (2022), noting that freebies offered to doctors can affect prescriptions and ultimately harm patients.

What Is UCPMP 2024 And Why Is It Important

The Central Government introduced the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, on March 12, 2024. The code sets ethical standards for pharmaceutical companies when promoting medicines and interacting with doctors and other healthcare professionals.

The Department of Pharmaceuticals is responsible for overseeing the code’s implementation. Its provisions include rules on gifts, monetary benefits, hospitality and support for medical conferences and educational events.

The government has also established a system for handling complaints, reviewing alleged violations and hearing appeals through designated committees. Pharmaceutical companies are expected to follow the code and meet applicable disclosure requirements. However, the central issue before the Supreme Court is whether the existing framework provides sufficiently effective and enforceable safeguards against unethical practices by pharmaceutical companies.

The Court’s latest direction seeks a detailed review of these safeguards and possible improvements to monitoring, accountability and enforcement.

Pharma Marketing Rules: Why Does The Court Want Stronger Legal Regulations

The Court’s concern is that an ethical code may not achieve its purpose if violations cannot be effectively prevented or punished.

During the proceedings, questions were raised about the difference between action against doctors who accept improper benefits and the measures available to regulate pharmaceutical companies that offer those benefits.

The petitioners argued that stronger legal provisions were needed to hold pharmaceutical companies accountable, rather than relying only on the existing system.

The Court also noted that the effectiveness of regulation must be judged by its implementation and enforcement, not merely by the existence of written rules.

What Will The New Committee Examine

The committee has been directed to undertake a comprehensive review of the issues related to unethical pharmaceutical marketing practices. Its key responsibilities include:

  • Reviewing Existing Laws: Examining whether current laws and regulations are sufficient to control unethical marketing.
  • Checking Enforcement Mechanisms: Assessing how existing rules are monitored and enforced.
  • Consulting Stakeholders: Giving petitioners, intervenors and other concerned stakeholders an opportunity to share their views and suggestions.
  • Seeking Expert Advice: Taking assistance from technical experts, professional bodies and relevant institutions when required.
  • Recommending Improvements: Suggesting measures to improve transparency, accountability and compliance across the pharmaceutical industry.

The committee must complete its work within two months of its first meeting and submit its recommendations to the Union Government.

Read also: This Supreme Court Observation Could Redefine How Public Office Is Viewed In India

FAQs

What Is UCPMP 2024 In India?

The Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, is a government-issued code that sets ethical standards for pharmaceutical companies when promoting medicines and interacting with healthcare professionals. It includes rules on gifts, monetary benefits, hospitality and other promotional activities.

Why Has The Supreme Court Asked The Government To Form A Committee On Pharma Marketing?

The Supreme Court has directed the Central Government to form a committee to examine unethical pharmaceutical marketing practices and recommend stronger regulations. The committee will assess whether existing rules are sufficient and how enforcement can be improved.

When Is The Next Hearing In The Supreme Court Case On Doctor Freebies?

The Supreme Court has scheduled the next hearing for January 29, 2027. The government is expected to submit a compliance affidavit detailing the committee’s formation, consultation process, recommendations and the action taken.


Indian Masterminds Stories
Join our WhatsApp Channel
ADVERTISEMENT
ADVERTISEMENT
Related Stories
ADVERTISEMENT
ADVERTISEMENT
NEWS
R Hithendra IPS
Who Is R Hithendra? 1996-Batch IPS Officer Appointed Bengaluru City Police Chief, Know His Career, Education & Awards
Chandigarh Police
Chandigarh Police Reshuffle: 4 IPS/DANIPS Officers Get New Charges, Rajesh Kumar Sharma Among Them
Karnataka Police
Karnataka Transfers 32 IPS Officers in Major Reshuffle, R Hithendra Named Bengaluru Police Chief as City Divided into 5 Commissionerates
Zero Ka Dum
BPCL Plans ₹9,000 Crore Bond Sale After Nearly Four Years to Fund Refinery Expansion and Petrochemical Projects 
MCL
MCL and TGGENCO Sign Long-Term Agreement for 6.57 MTPA Coal Supply to Telangana's Yadadri Power Plant 
Madhya Pradesh Cabinet
MP Cabinet Approves Major Industrial Parks, Rs 1,507 Crore MSME Scheme, Floating Solar Project and 72 NDPS Court Posts
CM Mohan Seva Sankalp Abhiyan
Madhya Pradesh Cabinet Removes Two-Child Norm for Government Employees, Approves Six Special NDPS Courts
Bihar Cabinet Decisions 2026
Bihar Cabinet Approves 15 Proposals, Banka and Jamui Mineral Block Auctions Expected to Generate Over Rs 5,000 Crore
ADVERTISEMENT
ADVERTISEMENT
Videos
Five years after Kargil, India sent its cricketing heroes to Pakistan where terrorism posed a deadly threat. The man guarding them, former Special Director of Intelligence Bureau, Mr. Yashovardhan Azad, reveals what all went behind the scenes during that crucial tour. 
Trust No One, Said His Instinct in Pakistan
Gajendra Singh Shekhawat
How India Plans to Boost Tourism, Create Jobs and Ease Overcrowding : Gajendra Singh Shekhawat on the Road to 2047
Dr Saket Badola IFS
Beyond Tigers and Safaris: How Corbett Literature Festival Wants to Change the Conservation Conversation
ADVERTISEMENT
UPSC Stories
Mayank Gurjar
He Lost His Father in Class 12, Then Cleared UPSC in One Attempt to Become an IPS Officer
After losing his father in Class 12, Mayank Gurjar held on to his dream of public service, graduated...
Gautam UPSC
He Studied at 4 AM in a 10×10 Mumbai Slum Room; Today, Gautam Padibhar is an Indian Forest Service Officer
Meet IFS officer Gautam Padhibhar, a 2023-batch Chhattisgarh cadre officer who rose from financial hardship...
Aniket Sagar ICoAS
No Coaching, Full-Time Job and Two Attempts: How Aniket Sagar Cleared ICoAS
Aniket Sagar, a chartered accountant from Bundelkhand, cleared UPSC ICoAS 2025 after working at PwC,...
CSR NEWS
Coal India CSR Programme
Coal India Organises CSR Programme to Align Mining Operations with Community Development 
Initiative Aims to Strengthen CSR Implementation in Coal-Bearing Regions and Improve Community Well-Being...
hurl
HURL Signs MoU with Injot Trust to Launch Project ANGOR for Children's Education in Assam
The three-year CSR initiative will cover five locations in Assam, focusing on holistic education, digital...
cmpdil
CMPDIL Partners with Tata Steel Foundation to Upgrade Technical Education at ITI Tamar 
The project will modernise training infrastructure with robotic welding technology, digital learning...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Latest
R Hithendra IPS
Who Is R Hithendra? 1996-Batch IPS Officer Appointed Bengaluru City Police Chief, Know His Career, Education & Awards
Chandigarh Police
Chandigarh Police Reshuffle: 4 IPS/DANIPS Officers Get New Charges, Rajesh Kumar Sharma Among Them
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Videos
Five years after Kargil, India sent its cricketing heroes to Pakistan where terrorism posed a deadly threat. The man guarding them, former Special Director of Intelligence Bureau, Mr. Yashovardhan Azad, reveals what all went behind the scenes during that crucial tour. 
Gajendra Singh Shekhawat
Dr Saket Badola IFS
ADVERTISEMENT
ADVERTISEMENT